Product
188Re-NM-02
1 clinical trial
2 indications
Indication
Breast CancerIndication
RadiotoxicityClinical trial
Technetium-99m/Rhenium-188 Labeled Anti-HER2 Single Domain Antibody (99mTc/188Re-NM-02) for HER2 Expression Detection and Radionuclide Therapy in Breast CancerStatus: Recruiting, Estimated PCD: 2024-03-08